EMA
approval
· 2022-05-20
First treatment for children with Progeria or progeroid like syndromes (rare premature aging syndromes)
Summary
EMA announces first treatment for children with Progeria and other progeroid syndromes, offering a targeted option for these rare premature aging conditions.
Upgrade for the full analysis, importance score, and drug timeline.